Compare STRO & ADV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STRO | ADV |
|---|---|---|
| Founded | 2003 | 1987 |
| Country | United States | United States |
| Employees | 133 | 73000 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 524.8M | 438.2M |
| IPO Year | N/A | N/A |
| Metric | STRO | ADV |
|---|---|---|
| Price | $25.43 | $42.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | $31.33 | ★ $45.83 |
| AVG Volume (30 Days) | ★ 255.3K | 76.6K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $0.63 |
| Revenue Next Year | N/A | $0.45 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.67 | $0.49 |
| 52 Week High | $43.85 | $46.80 |
| Indicator | STRO | ADV |
|---|---|---|
| Relative Strength Index (RSI) | 30.61 | 69.76 |
| Support Level | $23.43 | $1.00 |
| Resistance Level | $27.96 | $46.80 |
| Average True Range (ATR) | 3.47 | 4.11 |
| MACD | -1.79 | -0.39 |
| Stochastic Oscillator | 0.40 | 73.73 |
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
Advantage Solutions Inc provides outsourced sales, marketing, merchandising, sampling, and retailer support services to consumer packaged goods manufacturers and retailers across North America. Its services are designed to support distribution, retail execution, shopper engagement, and private brand development across both physical and digital commerce environments. The company serves various clients across grocery, mass, club, retail pharmacy, convenience, and other channels. It operates through three reportable segments: Branded Services, Experiential Services, and Retailer Services. The majority of the revenue is derived from the Experiential Services segment, which provides in-store and digital sampling programs, demonstrations, and experiential events for manufacturers and retailers.